Did COVID change a deadly fungus? study looks at cancer patients
NCT ID NCT06900114
Summary
This study looked back at medical records to understand how the COVID-19 pandemic affected a serious fungal infection called mucormycosis in people with blood cancers. Researchers compared 60 patients from before and during the pandemic to see if infection rates, diagnosis methods, treatments, or costs changed. The goal is to learn from this experience to better manage this infection in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
Conditions
Explore the condition pages connected to this study.